News | September 15, 2009

Medical-Device Makers to Pay $40 Billion in Fees

Finance Committee Chairman Sen. Max Baucus (D., Mont.).

September 15, 2009 - The Finance Committee in a health-overhaul bill calls for device makers to pay $40 billion in fees over 10 years, with the specific amount based on each company's market share.

Meanwhile, medical-device manufacturers are rushing to reverse billions of dollars in fees proposed by the Senate Finance Committee. The fees resulted from a lobbying move where medical device-makers went to the White House this spring to volunteer financial concessions as part of an overhaul where they were asked to provide a financial figures in savings. The companies suggested that instead the government should tax hospital-purchasing groups (GPOs) that negotiate for lower prices on medical supplies and some devices. This way, they reasoned, the GPOs would pass on some or all of that tax to the device makers.

Finance Committee Chairman Sen. Max Baucus (D., Mont.), plans to make public his bill today, and the new fees on device makers' revenues are expected to be part of the new law. According to the bill, all manufacturers would be assessed at a rate based upon their U.S. sales to generate $4 billion annually beginning in 2010.

Some say the government believes device makers will greatly benefit from an overhaul because wider insurance coverage will bring them more customers, and the White House wants savings commitments to help pay for the package.

Related Content

NIH Study of Brain Energy Patterns Provides New Insights into Alcohol Effects

NIH scientists present a new method for combining measures of brain activity (left) and glucose consumption (right) to study regional specialization and to better understand the effects of alcohol on the human brain. Image courtesy of Ehsan Shokri-Kojori, Ph.D., of NIAAA.

News | Neuro Imaging | March 22, 2019
March 22, 2019 — Assessing the patterns of energy use and neuronal activity simultaneously in the human brain improve
PET Scans Show Biomarkers Could Spare Some Breast Cancer Patients from Chemotherapy
News | PET Imaging | March 18, 2019
A new study positron emission tomography (PET) scans has identified a biomarker that may accurately predict which...
Researchers Create New Method for Developing Cancer Imaging Isotopes

Prototype fluidic system for zirconium-89 purification. Image taken through a hot cell window at the Department of Radiology, University of Washington. Image courtesy of Matthew O’Hara, Pacific Northwest National Laboratory

News | Radiopharmaceuticals and Tracers | March 14, 2019
A team of researchers at the University of Washington announced they developed a new automated system for producing...
Siemens Healthineers Announces First U.S. Install of Biograph Vision PET/CT
News | PET-CT | March 06, 2019
Siemens Healthineers’ new Biograph Vision positron emission tomography/computed tomography (PET/CT) system has been...
ImaginAb Enrolls First Patient in Phase II PET Agent Clinical Trial
News | Radiopharmaceuticals and Tracers | January 30, 2019
ImaginAb Inc. announced the enrollment of the first patient in the Phase II clinical trial of the company’s CD8+ T Cell...
FDA Clears United Imaging Healthcare uExplorer Total-Body Scanner
Technology | PET-CT | January 23, 2019
January 23, 2019 — United Imaging Healthcare (United Imaging) announced U.S.
Subtle Medical Receives FDA Clearance, CE Mark for SubtlePET
Technology | PET Imaging | December 05, 2018
Subtle Medical announced 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market SubtlePET. Subtle...
Mirada Medical Joins U.K. Consortium Exploring Healthcare AI
News | Artificial Intelligence | December 04, 2018
Mirada Medical, a leading global brand in medical imaging software, will form part of an artificial intelligence (AI)...
Artificial Intelligence Predicts Alzheimer's Years Before Diagnosis
News | Neuro Imaging | November 14, 2018
Artificial intelligence (AI) technology improves the ability of brain imaging to predict Alzheimer’s disease, according...